A Study of MLN8054 in Patients With Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Colon Neoplasm|Pancreatic Neoplasm|Bladder Neoplasm
Interventions: DRUG: MLN8054
Sponsor: Millennium Pharmaceuticals, Inc.